1. Home
  2. SSTK vs TBPH Comparison

SSTK vs TBPH Comparison

Compare SSTK & TBPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SSTK
  • TBPH
  • Stock Information
  • Founded
  • SSTK 2003
  • TBPH 2013
  • Country
  • SSTK United States
  • TBPH United States
  • Employees
  • SSTK N/A
  • TBPH N/A
  • Industry
  • SSTK EDP Services
  • TBPH Biotechnology: Pharmaceutical Preparations
  • Sector
  • SSTK Technology
  • TBPH Health Care
  • Exchange
  • SSTK Nasdaq
  • TBPH Nasdaq
  • Market Cap
  • SSTK 724.0M
  • TBPH 699.0M
  • IPO Year
  • SSTK 2012
  • TBPH N/A
  • Fundamental
  • Price
  • SSTK $20.87
  • TBPH $14.05
  • Analyst Decision
  • SSTK Buy
  • TBPH Strong Buy
  • Analyst Count
  • SSTK 4
  • TBPH 3
  • Target Price
  • SSTK $43.67
  • TBPH $21.33
  • AVG Volume (30 Days)
  • SSTK 196.0K
  • TBPH 584.2K
  • Earning Date
  • SSTK 10-28-2025
  • TBPH 11-11-2025
  • Dividend Yield
  • SSTK 6.24%
  • TBPH N/A
  • EPS Growth
  • SSTK 38.48
  • TBPH N/A
  • EPS
  • SSTK 1.81
  • TBPH 0.26
  • Revenue
  • SSTK $1,010,504,000.00
  • TBPH $77,205,000.00
  • Revenue This Year
  • SSTK $11.52
  • TBPH $78.36
  • Revenue Next Year
  • SSTK $1.15
  • TBPH N/A
  • P/E Ratio
  • SSTK $11.66
  • TBPH $52.86
  • Revenue Growth
  • SSTK 14.20
  • TBPH 24.49
  • 52 Week Low
  • SSTK $14.35
  • TBPH $7.88
  • 52 Week High
  • SSTK $38.80
  • TBPH $14.55
  • Technical
  • Relative Strength Index (RSI)
  • SSTK 53.42
  • TBPH 69.92
  • Support Level
  • SSTK $19.98
  • TBPH $13.47
  • Resistance Level
  • SSTK $21.29
  • TBPH $14.36
  • Average True Range (ATR)
  • SSTK 0.66
  • TBPH 0.42
  • MACD
  • SSTK -0.06
  • TBPH -0.08
  • Stochastic Oscillator
  • SSTK 54.22
  • TBPH 63.26

About SSTK Shutterstock Inc.

Shutterstock Inc is a U.S.-based company that is engaged in the provision of digital content. The content segment, whose offerings include licenses for Images, Footage, Music, 3 Dimensional, and Generative AI content. Data, Distribution, and Service offerings address customer demand for products and services that are beyond its Content licenses. The company generates the majority of its revenue from Content offerings. Geographically the company generates the majority of its revenue from the Domestic market, but also has its presence in Europe and Rest of the Countries.

About TBPH Theravance Biopharma Inc.

Theravance Biopharma Inc is a diversified biopharmaceutical company focused on the discovery, development, and commercialization of organ-selective medicines. Its purpose is to pioneer a new generation of small-molecule drugs designed to meet patient needs. Its research is focused on the areas of inflammation and immunology. The firm applies organ-selective expertise to target disease biologically, to discover and develop medicines that may expand the therapeutic index with the goal of maximizing efficacy and limiting systemic side effects. The company develops lung-selective medicines to treat respiratory disease, including FDA-approved YUPELRI (revefenacin) inhalation solution indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD).

Share on Social Networks: